These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19500993)

  • 21. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
    Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
    Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione.
    Ahmadi A; Khalili M; Sohrabi L; Delzendeh N; Nahri-Niknafs B; Ansari F
    Mini Rev Med Chem; 2017; 17(8):721-726. PubMed ID: 27903228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
    Cerón-Romero L; Paoli P; Camici G; Flores-Morales V; Rios MY; Ramírez-Espinosa JJ; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2018-22. PubMed ID: 26961283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of novel sulindac derivatives as partial agonists of PPARγ with potential anti-diabetic efficacy.
    Huang F; Zeng Z; Zhang W; Yan Z; Chen J; Yu L; Yang Q; Li Y; Yu H; Chen J; Wu C; Zhang XK; Su Y; Zhou H
    Eur J Med Chem; 2021 Oct; 222():113542. PubMed ID: 34118723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C; Alam MS; Hamid H; Javed K; Shafi S; Ali Y; Alam P; Pasha MA; Dhulap A; Bano S; Nazreen S; Haider S
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5298-303. PubMed ID: 25442322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists.
    Ibrahim MK; Eissa IH; Abdallah AE; Metwaly AM; Radwan MM; ElSohly MA
    Bioorg Med Chem; 2017 Feb; 25(4):1496-1513. PubMed ID: 28117121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Biguanides as Anti-Diabetic Agents, Part II: Synthesis and Anti-Diabetic Properties Evaluation of 1-Arylamidebiguanide Derivatives as Agents of Insulin Resistant Type II Diabetes.
    Basyouni WM; Abbas SY; El Shehry MF; El-Bayouki KAM; Aly HF; Arafa A; Soliman MS
    Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Hybrids of Pyrazolidinedione and Benzothiazole as TZD Analogues. Rationale Design, Synthesis and In Vivo Anti-Diabetic Evaluation.
    Haroun M
    Med Chem; 2019; 15(6):624-633. PubMed ID: 31113352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model.
    Bhutani R; Pathak DP; Kapoor G; Husain A; Kant R; Iqbal MA
    Bioorg Chem; 2018 Apr; 77():6-15. PubMed ID: 29316509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action.
    Ladopoulou E; Matralis AN; Kourounakis AP
    J Med Chem; 2013 Apr; 56(8):3330-8. PubMed ID: 23581491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents.
    Sekhar KC; Syed R; Golla M; Kumar M V J; Yellapu NK; Chippada AR; Chamarthi NR
    Daru; 2014 Dec; 22(1):76. PubMed ID: 25542373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current anti-diabetic agents and their molecular targets: A review.
    Kerru N; Singh-Pillay A; Awolade P; Singh P
    Eur J Med Chem; 2018 May; 152():436-488. PubMed ID: 29751237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats.
    Rani R; Dahiya S; Dhingra D; Dilbaghi N; Kim KH; Kumar S
    Eur J Pharm Sci; 2017 Aug; 106():220-230. PubMed ID: 28595874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics.
    Li R; Wu J; He Y; Hai L; Wu Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1762-5. PubMed ID: 24613165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.
    Hu Y; Wang B; Yang J; Liu T; Sun J; Wang X
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):15-30. PubMed ID: 30362362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
    Basyouni WM; Abbas SY; El-Bayouki KAM; Younis EA; Ali SA; Aly HF
    Bioorg Chem; 2021 Dec; 117():105418. PubMed ID: 34736133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Evaluation of 1-Substituted-Biguanide Derivatives as Anti-Diabetic Agents for Type II Diabetes Insulin Resistant.
    Abbas SY; Basyouni WM; El-Bayouki KA; Abdel-Rahman RF
    Drug Res (Stuttg); 2016 Jul; 66(7):377-83. PubMed ID: 27191826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Piperine Derivatives with Antidiabetic Effect as PPAR-γ Agonists.
    Kharbanda C; Alam MS; Hamid H; Javed K; Bano S; Ali Y; Dhulap A; Alam P; Pasha MA
    Chem Biol Drug Des; 2016 Sep; 88(3):354-62. PubMed ID: 27037532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of sulfonamide derivatives of pyrrolidine and piperidine as anti-diabetic agents.
    Sharma R; Soman SS
    Eur J Med Chem; 2015 Jan; 90():342-50. PubMed ID: 25437620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design.
    Sheng R; Yang L; Zhang Y; Xing E; Shi R; Wen X; Wang H; Sun H
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2599-2604. PubMed ID: 29980358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.